Tue.Jan 28, 2025

article thumbnail

Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging

MedCity News

Quibims technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startups customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.

Medical 117
article thumbnail

FDA approves new Alzheimer’s treatment regimen

PharmaTimes

Patients and care partners may find once every four weeks maintenance dosing easier

FDA 106
article thumbnail

We Need to Talk About Hospice

MedCity News

It’s a place where compassion and dignity are paramount, where patients and families find solace and support during the most challenging times. We owe it to them to ensure that hospice care is of the highest quality, accessible to all and integrated into the broader continuum of care. The post We Need to Talk About Hospice appeared first on MedCity News.

Patients 109
article thumbnail

AI in medical imaging company Quibim raises $50m

pharmaphorum

Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.

Medical 76
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases

MedCity News

The structure of Atalanta Therapeutics RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntingtons disease and a rare inherited form epilepsy are on track to enter the clinic this year. The post RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases appeared first on MedCity News.

article thumbnail

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

Eversana Intouch

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles.

More Trending

article thumbnail

Cartesian Therapeutics announces FDA agreement for new trial

PharmaTimes

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25

FDA 66
article thumbnail

Many Community Pharmacists Won’t Carry Drugs in Medicare Negotiation Program, NCPA Warns

MedCity News

According to the National Community Pharmacists Association, 60.4% of independent pharmacists are weighing not stocking one or more of the first 10 drugs in the Medicare Drug Price Negotiation program. Another 32.8% have already decided not to stock one or more of the drugs. The post Many Community Pharmacists Wont Carry Drugs in Medicare Negotiation Program, NCPA Warns appeared first on MedCity News.

70
article thumbnail

Bringing drugs to market has ‘never been more challenging,’ and pharma is learning to adapt

PharmaVoice

As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.

Pharma 65
article thumbnail

AB2 Bio and Nippon Shinyaku enter Tadekinig alfa licensing deal

Pharmaceutical Technology

AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise Tadekinig alfa.

64
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

FDA Approves Semaglutide to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease

Pharmacy Times

The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.

FDA 63
article thumbnail

Veru shares plunge despite positive data in obesity trial

pharmaphorum

Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.

61
article thumbnail

Lantheus Announces Agreement to Acquire Evergreen Theragnostics

PharmaTech

The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.

59
article thumbnail

Sage rejects Biogen takeover and launches review

pharmaphorum

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

59
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

How Dual-Eligible Special Needs Plans Affect Medicaid Spending

Pharmaceutical Commerce

A study explores dual-enrollment in these planscompared to other Medicare Advantage plans impacts North Carolinas Medicaid fee-for-service spending.

article thumbnail

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial

Pharmaceutical Technology

the company announced that its Phase III trial examining its gastroenteropancreatic tumour treatment, ITM-11, met its primary endpoint.

59
article thumbnail

Stopwatch starts on reviews of GSK's long-acting asthma drug

pharmaphorum

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

57
article thumbnail

Allakos cuts 75% of workforce after chronic hives trial failure 

Pharmaceutical Technology

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.

59
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Hydroxychloroquine Enhances the Efficacy of Palbociclib, Letrozole Therapy in Patients With HR+, HER2– Metastatic Breast Cancer

Pharmacy Times

Endocrine therapy in combination with CDK4/6 inhibitors improves patients outcomes, but many still become treatment resistant.

article thumbnail

GLP-1RA developer Metsera targets $289m IPO

Pharmaceutical Technology

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

59
article thumbnail

Enhertu gets first okay for HER2-ultralow breast cancer

pharmaphorum

Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.

FDA 54
article thumbnail

Can-Fite BioPharma secures US patent for Namodenoson

Pharmaceutical Technology

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

New analysis asserts survival benefit for Roche breast cancer therapy

European Pharmaceutical Review

Updated Phase III analysis show that Itovebi TM (inavolisib) in combination with palbociclib (Ibrance ) and fulvestrant provided a statistically significant and clinically meaningful overall survival benefit in a type of HR-positive advanced breast cancer. This was compared to palbociclib and fulvestrant only. The combination treatment more than doubled progression-free survival, according to Roches Phase III INAVO120 study results in PIK3CA-mutated, hormone receptor (HR)-positive, human epider

Medical 52
article thumbnail

OCT West Coast 2025: Efficient trials will help at all levels

Pharmaceutical Technology

Arena Internationals Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and regulatory shifts.

article thumbnail

Key Considerations for Onboarding and Implementing DSCSA Services With Your 3PL Partner With Speed and Compliance

Pharmaceutical Commerce

Starting May 27, 2025, the FDAs DSCSA enforcement will require all supply chain stakeholders to implement and test serialization and tracking processes to meet compliance.

52
article thumbnail

Sage rejects Biogen’s $469m takeover bid

Pharmaceutical Technology

Sages board of directors said that the proposal significantly undervalues the company and is not in the best interest of shareholders.

59
article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

New Spravato Indication Offers Greater Flexibility and Personalization for Patients with Treatment-Resistant Depression

PharmExec

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression.

article thumbnail

AI-driven virtual CGM data boosts understanding of T1D risks

Pharmaceutical Technology

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.

article thumbnail

FDA Approves AstraZeneca, Daiichi Sankyo’s Enhertu for Unresectable or Metastatic Hormone Receptor-Positive, HER2-Low Breast Cancer

PharmExec

Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer.

FDA 52
article thumbnail

GSK and University of Oxford partner for cancer vaccine research

Pharmaceutical Technology

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.

59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven